{"doi":"10.1007/s40119-025-00422-8","title":"Transthyretin Kinetic Stabilizers for ATTR Amyloidosis","abstract":"Two transthyretin (TTR) stabilizers, tafamidis and acoramidis, are currently approved for transthyretin amyloidosis (ATTR amyloidosis).Tafamidis and acoramidis share the same mechanism of action, but perceived disparities in their biochemical and pharmacokinetic properties and pivotal clinical trial outcomes have become topics of intense scientific debate.","journal":"Cardiology and Therapy","year":2025,"id":532728,"datarank":0.20794415416798362,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.0,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9496,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":249877,"name":"Jeffery W. Kelly","orcid":"0000-0001-8943-3395","position":0,"is_corresponding":true}],"reference_count":21,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:51:27.893975Z","pmid":"40730934","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}